Devices › Forceps, biopsy, non-electric
Device brand name · Disposable biopsy forceps
Disposable Biopsy Forceps: medical device reports filed with FDA
201 reports name it, 2007–2026. Manufacturer given most often on reports: Olympus Medical Systems. Product code FCL.
- 201
- device reports naming the brand
- 0% of all MAUDE reports · about 11 a year
- 8
- reports, 12 months to August 2026
- 16 in the 12 months before
- 45.3%
- classified as malfunction
- 72.3% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 201 reports that name the brand "Disposable Biopsy Forceps" (disposable biopsy forceps), received between June 2007 and June 2026; the manufacturer given most often on reports is Olympus Medical Systems. Spellings of one product vary from report to report.
8 reports arrived in the 12 months to August 2026, down 50% from 16 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (53.7%) and malfunction (45.3%); across all forceps, biopsy, non-electric reports (product code FCL) death is recorded in 0.6% and malfunction in 72.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are break (21.4%), dull, blunt (9.5%) and failure to cut (9.5%). The patient problems coded most often are hemorrhage/blood loss/bleeding, blood loss and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 2,711 reports carrying product code FCL. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Breakthe device broke | 43 | 21.4% | 9% |
| Dull, blunt | 19 | 9.5% | 2% |
| Failure to cut | 19 | 9.5% | 2.9% |
| Mechanical problema mechanical problem | 15 | 7.5% | 1.3% |
| Device handling problem | 8 | 4% | 0.4% |
| Detachment of device or device componentpart of the device came off | 5 | 2.5% | 0.5% |
| Insufficient device problem information | 4 | 2% | 2.8% |
| Component missing | 2 | 1% | 0.5% |
| Device reprocessing problem | 2 | 1% | 0.3% |
| Retraction problem | 2 | 1% | 0.3% |
| Contamination | 1 | 0.5% | 0.1% |
| Defective devicethe device was defective | 1 | 0.5% | 0.3% |
| Device dislodged or dislocated | 1 | 0.5% | 0% |
| Device operates differently than expectedthe device behaved unexpectedly | 1 | 0.5% | 15.8% |
| Difficult to open or close | 1 | 0.5% | 5.1% |
| Failure to clean adequately | 1 | 0.5% | 0.1% |
| Fracturea broken bone | 1 | 0.5% | 1.7% |
| Loose or intermittent connection | 1 | 0.5% | 0.1% |
| Material split, cut or torn | 1 | 0.5% | 0% |
| Residue after decontamination | 1 | 0.5% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hemorrhage/blood loss/bleeding | 28 | 13.9% |
| Blood loss | 26 | 12.9% |
| Tissue damage | 16 | 8% |
| Hematomaa collection of blood under the skin or in tissue | 14 | 7% |
| Pneumothoraxa collapsed lung | 11 | 5.5% |
| Device embedded in tissue or plaque | 4 | 2% |
| Excessive tear production | 4 | 2% |
| Injurya physical injury | 4 | 2% |
| Laceration(s) | 4 | 2% |
| Gastrointestinal hemorrhage | 3 | 1.5% |
| Foreign body in patientpart of a device left in the patient | 2 | 1% |
| Low oxygen saturation | 2 | 1% |
| Pneumonialung infection | 2 | 1% |
| Alteration in body temperature | 1 | 0.5% |
| Bruise/contusion | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Disposable Biopsy Forceps | Product code FCL | All MAUDE reports |
|---|---|---|---|
| Reports | 201 | 2,711 | 26,136,888 |
| Share of that pool | — | 7.4% | 0% |
| Classified as death, per 1,000 reports | 0 | 6 | 9 |
| Classified as injury | 53.7% | 26% | 36.2% |
| Classified as malfunction | 45.3% | 72.3% | 62.3% |
| Filed by the manufacturer | 95.5% | 93.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code FCL
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Radial Jaw 4 Biopsy Forceps | 399 | 0 | 1% |
| Radial Jaw 4 | 403 | 22 | 0.5% |
| Radial Jaw 3 Biopsy Forceps | 302 | 0 | 0% |
| Captura Serrated Forceps With Spike | 223 | 0 | 0% |
| Karl Storz | 633 | 0 | 2.1% |
| Boston Scientific | 580 | 5 | 3.3% |
| Instinct Endoscopic Hemoclip | 784 | 0 | 0.1% |
| Superdimension | 227 | 5 | 7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Disposable Biopsy Forceps reports
How many FDA reports name Disposable Biopsy Forceps?
201 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 8 in the latest 12 months.
What kinds of events are reported?
injury (53.7%) and malfunction (45.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
break (21.4%), dull, blunt (9.5%), failure to cut (9.5%), mechanical problem (7.5%) and device handling problem (4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (95.5%) and distributor reports (3.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Disposable Biopsy Forceps was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.